£40.5M
Pfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.
Curve Therapeutics develops a Microcycle platform for intracellular cancer drug discovery.
Southampton-based biotech startup developing an intracellular screening platform to tackle complex cancer targets.
Simon Kerry
Chief Executive Officer

Ali Tavassoli
Chief Scientific Officer
Ali serves as a professor of chemical biology at the University of Southampton and cofounded Curve Therapeutics, where he is chief scientific officer. He previously presided over the Chemistry and Biology Interface Division at the Royal Society of Chemistry.
LinkedInPfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.